El VHIO és un destacat centre oncològic integral d’excel·lència en el qual els científics i doctors adopten un model de recerca purament translacional, treballant en equips multidisciplinaris per d’accelerar i avançar en el camp de les teràpies personalitzades i específiques contra el càncer. Scientia recull part de la seva producció científica per tal que es pugui compartir i difondre.

Si sou personal del Vall d'Hebron Institut d'Oncologia VHIO i voleu incorporar els materials de recerca en format electrònic que heu produït en la vostra activitat professional dins de l’Hospital, contacteu amb bibliotecahuvh@vallhebron.cat

Collections in this community

VHIO - Articles científics [1250]
VHIO - Dades primàries [0]
VHIO - Documents de recomanacions i protocols [1]

Recent Submissions

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

Kumari, Nishi; Wright, Sarah Christine Elisabeth; Witham, Christopher; Monserrat, Laia; Palafox Sánchez, Marta; Richard, John L. C.; Serra, Violeta (American Society for Clinical Investigation, 2025-11-17)
Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications

Bacca, Luisa; Zivi, Andrea; Labbé, David; Brandariz, Julian; Zacchi, Francesca; Mateo, Joaquin (Elsevier, 2025-11-20)
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC

Ahn, Myung-Ju; Lisberg, Aaron; Sands, Jacob; Goto, Yasushi; Hong, Min Hee; Paz-Ares, Luis; FELIP, ENRIQUETA (Elsevier, 2025-11)
Breastfeeding after breast cancer in young BRCA carriers

DELUCCHI, VIRGINIA; Ferrari, Alberta; Blondeaux, Eva; Mariamidze, Elene; Bernstein Molho, Rinat; Frank, Sophie; Balmaña, Judith (Oxford University Press, 2025-11)
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

Diego, Daniela S.; Kammler, Roswitha; Demeestere, Isabelle; Niman, Samuel; Partridge, Ann; Ruggeri, Monica; Saura Manich, Cristina (Elsevier, 2025-12)

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO

Collections in this community

VHIO - Articles científics [1250]

VHIO - Dades primàries [0]

VHIO - Documents de recomanacions i protocols [1]

Recent Submissions

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC

Breastfeeding after breast cancer in young BRCA carriers

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO

Collections in this community

VHIO - Articles científics [1250]

VHIO - Dades primàries [0]

VHIO - Documents de recomanacions i protocols [1]

Recent Submissions

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer ﻿

Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications ﻿

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC ﻿

Breastfeeding after breast cancer in young BRCA carriers ﻿

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547] ﻿

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC

Breastfeeding after breast cancer in young BRCA carriers

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]